Kaiser Permanente Northwest Region Oncology/Hematology

Portland, Oregon 97227-1110

0 studies enrolling now · 5 studies all time

What they study most

Breast Cancer, Carcinoma, Pancreatic Ductal, Colorectal Cancer, Metastatic or Unresectable Cutaneous Melanoma, Pancreatic Adenocarcinoma, Pancreatic Cancer, Pancreatic Disease

Studies at this site

• Study of the Safety and Efficacy of TH-302 in Combination With Gemcitabine Compared With Gemcitabine Alone in Previously Untreated Patients With Pancreatic Adenocarcinoma — Completed
• Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer — Completed
• Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma — Completed
• Efficacy and Safety of Simtuzumab (SIM) With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma — Stopped early
• A Study of AGS-1C4D4 Given in Combination With Gemcitabine in Subjects With Metastatic Pancreatic Cancer — Completed